Alpha interferon in the management of essential thrombocythaemia
- 31 December 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27, S72-S74
- https://doi.org/10.1016/0277-5379(91)90579-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Recombinant interferon-alpha, but not interferon-gamma is effective therapie for essential thrombocythemiaAnnals of Hematology, 1990
- Interferon-alpha-induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosisBritish Journal of Haematology, 1990
- Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosisThe American Journal of Medicine, 1989
- LONG-TERM INTERFERON THERAPY FOR THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISEASESThe Lancet, 1989
- Game theoretic analysis of interferons effect on hematopoietic progenitors growthMedical Hypotheses, 1988
- ALPHA-INTERFERON THERAPY FOR ESSENTIAL THROMBOCYTHAEMIAThe Lancet, 1988
- Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disordersCancer Immunology, Immunotherapy, 1987
- Effect of recombinant interferons alpha and gamma on human bone marrow- derived megakaryocytic progenitor cellsBlood, 1987
- Phase I Study of Recombinant Human Interferon Alpha-2C in Patients with Chemotherapy-Refractory MalignanciesOncology, 1985
- Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cellBlood, 1981